Janus Henderson Group PLC Precigen, Inc. Transaction History

Janus Henderson Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.88 - $2.19 $23,086 - $57,454	26,235 Added 146.17%	44,183 $46,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $2.53 $714 - $1,571	-621 Reduced 3.34%	17,948 $24,000
Q1 2022 May 16, 2022	SELL	$1.91 - $3.98 $5 - $11	-3 Reduced 0.02%	18,569 $39,000
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $65,559 - $102,146	18,572 New	18,572 $69,000

140

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $281M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.